Trials / Unknown
UnknownNCT01962181
Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
Identifying Characteristic Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
In this study we try to identify the signature of brain activity in the EEG of attention deficit disorder (ADHD) patients compared to healthy subjects under different doses of Ritalin (methylphenidate) treatment.
Detailed description
In this study we try to identify the signature of brain activity in the EEG of attention deficit disorder (ADHD) patients compared to healthy subjects under different doses of Ritalin (methylphenidate) treatment. All subjects will undergo 1-4 EEG sessions. In each session we will use a different dose of Ritalin or placebo. A detailed neuropsychological tests will be done during the EEG recording. A powerful machine-learning techniques will be used in order to find a specific signature of ADHD and Ritalin treatment in the EEG recording.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ritalin | Patients with ADHD and healthy subjects will be examined under Ritalin or placebo |
| DRUG | Placebo |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2013-10-14
- Last updated
- 2013-10-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01962181. Inclusion in this directory is not an endorsement.